JP2023531378A5 - - Google Patents

Info

Publication number
JP2023531378A5
JP2023531378A5 JP2022573571A JP2022573571A JP2023531378A5 JP 2023531378 A5 JP2023531378 A5 JP 2023531378A5 JP 2022573571 A JP2022573571 A JP 2022573571A JP 2022573571 A JP2022573571 A JP 2022573571A JP 2023531378 A5 JP2023531378 A5 JP 2023531378A5
Authority
JP
Japan
Prior art keywords
region
disease
composition according
modified treg
modified
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022573571A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023531378A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/034968 external-priority patent/WO2021243275A2/en
Publication of JP2023531378A publication Critical patent/JP2023531378A/ja
Publication of JP2023531378A5 publication Critical patent/JP2023531378A5/ja
Pending legal-status Critical Current

Links

JP2022573571A 2020-05-28 2021-05-28 神経変性疾患を治療するためのCAR-Treg系療法 Pending JP2023531378A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202063031261P 2020-05-28 2020-05-28
US63/031,261 2020-05-28
PCT/US2021/034968 WO2021243275A2 (en) 2020-05-28 2021-05-28 Car-treg-based therapies for treating neurgdegenerative diseases

Publications (2)

Publication Number Publication Date
JP2023531378A JP2023531378A (ja) 2023-07-24
JP2023531378A5 true JP2023531378A5 (https=) 2024-08-06

Family

ID=76808134

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022573571A Pending JP2023531378A (ja) 2020-05-28 2021-05-28 神経変性疾患を治療するためのCAR-Treg系療法

Country Status (6)

Country Link
US (1) US20230210899A1 (https=)
EP (1) EP4157877A2 (https=)
JP (1) JP2023531378A (https=)
CN (2) CN116568321A (https=)
IL (1) IL298501A (https=)
WO (1) WO2021243275A2 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3773629A4 (en) 2018-03-27 2022-01-19 AZTherapies, Inc. CAR-TREG-BASED THERAPIES FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES
JP7456638B2 (ja) * 2018-08-14 2024-03-27 ソティオ,リミティド ライアビリティ カンパニー クレブス回路を調節するトランス代謝分子と組み合わせたキメラ抗原受容体ポリペプチド、及び、それらの治療的使用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4166452A (en) 1976-05-03 1979-09-04 Generales Constantine D J Jr Apparatus for testing human responses to stimuli
US4256108A (en) 1977-04-07 1981-03-17 Alza Corporation Microporous-semipermeable laminated osmotic system
US4265874A (en) 1980-04-25 1981-05-05 Alza Corporation Method of delivering drug with aid of effervescent activity generated in environment of use
WO2010141801A2 (en) 2009-06-05 2010-12-09 Cellular Dynamics International, Inc. Reprogramming t cells and hematophietic cells
EP3773629A4 (en) * 2018-03-27 2022-01-19 AZTherapies, Inc. CAR-TREG-BASED THERAPIES FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES
JP7817159B2 (ja) * 2019-11-08 2026-02-18 メイヨ・ファウンデーション・フォー・メディカル・エデュケーション・アンド・リサーチ 炎症状態及び変性疾患を処置するために操作された間葉系幹細胞を使用する方法及び材料

Similar Documents

Publication Publication Date Title
US20220202714A1 (en) Cell penetrating peptide (cpp)-mediated ev loading
JP2022061992A5 (https=)
JP2022531911A5 (https=)
Hong et al. Chemoenzymatic Synthesis of a Rhamnose‐Functionalized Bispecific Nanobody as a Bispecific Antibody Mimic for Cancer Immunotherapy
JP2013135695A5 (https=)
JP2023531378A5 (https=)
FI4050034T3 (fi) Cd3:een sitoutuvia vasta-aineita
SI2740744T1 (en) Sp35 antibodies and their use
RU2014109039A (ru) Биспецифические антигенсвязывающие молекулы
JP2021531280A5 (https=)
CA2798390A1 (en) Compositions and methods of use for therapeutic low density lipoprotein - related protein 6 (lrp6) multivalent antibodies
JP7754507B2 (ja) 二重特異性結合剤を用いる表面タンパク質の分解
JP2016525545A5 (https=)
JP2010531140A5 (https=)
RU2013102225A (ru) АНТИТЕЛА ПРОТИВ Axl И СПОСОБЫ ИХ ПРИМЕНЕНИЯ
RU2011152816A (ru) ПРИМЕНЕНИЕ АНТИТЕЛА ПРОТИВ Tau pS422 ДЛЯ ЛЕЧЕНИЯ ЗАБОЛЕВАНИЙ ГОЛОВНОГО МОЗГА
JP2016502515A5 (https=)
RU2013108054A (ru) Антитела против а2 тенасцина с и способы их применения
JP7710706B2 (ja) 癌治療のための方法及び組成物
RU2014108309A (ru) Антиполиубиквитиновые антитела и способы применения
JP2022513331A5 (https=)
JP2014513941A5 (https=)
JP2021531834A5 (https=)
JP2023515708A5 (https=)
JP2015530989A5 (https=)